
<DOC>
<DOCNO>
WSJ900606-0134
</DOCNO>
<DOCID>
900606-0134.
</DOCID>
<HL>
   Financing Business:
   Gensia Pharmaceuticals Inc.
</HL>
<DATE>
06/06/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   GNSA
</CO>
<IN>
INITIAL STOCK OFFERINGS (INI)
STOCK MARKET, OFFERINGS (STK)
</IN>
<LP>
   GENSIA PHARMACEUTICALS Inc., San Diego, announced an
initial public offering of 2.8 million common shares at $11
each. Alex. Brown &amp; Sons Inc., Montgomery Securities and
Smith Barney, Harris Upham &amp; Co. will manage the
underwriters. Gensia said that if the underwriter's
over-allotment option to purchase an additional 420,000
shares is exercised, Gensia will have about 13,557,000 shares
outstanding after the offering. Gensia, which develops, makes
and markets novel pharmaceutical products, said it plans to
use net proceeds from the offering for funding research and
development and for general corporate purposes.
</LP>
<TEXT>
</TEXT>
</DOC>